Aalen, Germany | 01.April 2021 | ZEISS Vision Care
The latest Vision Atlas from the International Agency for Prevention of Blindness reports alarming statistics: Two to three billion people worldwide do not have access to eye care services. And the need for eye care is set to surge in the coming years. That is why ZEISS is working together with various partners to ensure that the world’s most deprived regions can also benefit from eyeglasses or eye care services. Here are some examples of current projects.
For several years, the Jeevan Rekha Express or Lifeline Express is the world's first hospital train covering the country's remote areas, providing free treatment to people in need. With its Aloka Vision Programme, ZEISS regularly participates and provides vision screening and eyeglasses. In October 2020, for example, 3,870 patients in Tripura underwent eye exams, and more than 1,000 pairs of glasses were made and dispensed. In addition to this, eye doctors also provide other services on the train, e.g. cataract surgery.
Good vision is essential for a child's educational, physical, and social development. It positively impacts their entire life. The "Drishti Eye Care System” and ZEISS are committed to providing vision tests, eye care, and glasses where needed. Drishti Eye Care is one of Nepal's leading eye hospitals dedicated to diagnosing and treating non-refractive visual impairments in children. ZEISS' contribution includes equipment for vision screening and helping the supply chain with customized eyewear. Together, ZEISS and Drishti Eye Care provide comprehensive eye care services for school classes. The goal for 2021: to provide eye care to at least 10,000 children.
The goals for the project in Nepal reflect experiences from around the world. In Karnataka, southern India, the Lions Club and ZEISS have been working together for years to organize "eye camps" for underprivileged children. This project shows how different strengths complement each other: The Lions Club maintains close relationships with public schools. The Aloka team knows how to effectively screen hundreds of pupils and provide quality eye care to all those in need. A perfect fit. The program was developed in partnership with the Optometry Council of India and Optometry Colleges' support, ensuring crucial quality and ethical standards are maintained – a must especially when treating children. In 2020, the program catered for 25,000 children but the face-to-face activities had to stop due to the pandemic. The program will resume in April 2021, with the necessary protective measures.
Each "Eye Camp" examines patients for cataracts whose vision can no longer be corrected with prescription glasses. Surgical treatment of cataracts is one of the most common operations worldwide. Wherever possible, the Aloka Vision Program from ZEISS works together with eye clinics and doctors to provide treatment for cataract patients.
Since 2015, ZEISS has been providing vision care in areas otherwise deprived of such care, predominantly in rural India. As a social venture, Aloka works with non-governmental organizations, medical institutions and colleges, and universities to provide quality eye care for refractive and non-refractive vision disorders. Aloka eyeglasses are custom-made with standard lenses and delivered to patients by its partners at an affordable price. For certain groups, such as children with special needs, ZEISS, Miracle of Sight e.V. (non-profit) or local foundations cover the treatment costs. Since September 2020 – after the end of the first worldwide lockdown – 62,800 patients have received treatment thanks to the Aloka program.
ZEISS is an internationally leading technology enterprise operating in the fields of optics and optoelectronics. In the previous fiscal year, the ZEISS Group generated annual revenue totaling 6.3 billion euros in its four segments Semiconductor Manufacturing Technology, Industrial Quality & Research, Medical Technology and Consumer Markets (status: 30 September 2020).
For its customers, ZEISS develops, produces and distributes highly innovative solutions for industrial metrology and quality assurance, microscopy solutions for the life sciences and materials research, and medical technology solutions for diagnostics and treatment in ophthalmology and microsurgery. The name ZEISS is also synonymous with the world's leading lithography optics, which are used by the chip industry to manufacture semiconductor components. There is global demand for trendsetting ZEISS brand products such as eyeglass lenses, camera lenses and binoculars.
With a portfolio aligned with future growth areas like digitalization, healthcare and Smart Production and a strong brand, ZEISS is shaping the future of technology and constantly advancing the world of optics and related fields with its solutions. The company's significant, sustainable investments in research and development lay the foundation for the success and continued expansion of ZEISS' technology and market leadership. ZEISS invests 13 percent of its revenue in research and development – this high level of expenditure has a long tradition at ZEISS and is also an investment in the future.
With over 32,000 employees, ZEISS is active globally in almost 50 countries with around 30 production sites, 60 sales and service companies and 27 research and development facilities. Founded in 1846 in Jena, the company is headquartered in Oberkochen, Germany. The Carl Zeiss Foundation, one of the largest foundations in Germany committed to the promotion of science, is the sole owner of the holding company, Carl Zeiss AG.
Further information at www.zeiss.com
ZEISS Vision Care is one of the world's leading manufacturers of eyeglass lenses and ophthalmic instruments. The unit is allocated to the Consumer Markets segment and develops and produces offerings for the entire eyeglass value chain that are distributed globally under the ZEISS brand.